SciELO - Scientific Electronic Library Online

 
vol.90 suppl.2Clinical prediction rules in acute appendicitis: which combination of variables is more effective at predicting?Mentoring: what to expect from our surgical mentors in Colombia? A Latin American example author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Cirugía y cirujanos

On-line version ISSN 2444-054XPrint version ISSN 0009-7411

Cir. cir. vol.90  suppl.2 Ciudad de México Dec. 2022  Epub Dec 20, 2023

https://doi.org/10.24875/ciru.21000489 

Original articles

Use of enhanced recovery after surgery protocol in laparoscopic cholecystectomy in patients with symptomatic cholelithiasis

Uso de protocolo de recuperación acelarada después de cirugía en colecistectomía laparoscópica para pacientes con colelitiasis sintomática

María de los Ángeles Mendoza-Vélez1 

Luis E. Cárdenas-Lailson2 

Erika Barlandas-Quintana2  * 

Asya Zubillaga-Mares2 

1División de Cirugía Plástica y Reconstructiva, Hospital General “Dr. Rubén Leñero”. Mexico City, Mexico

2División de Cirugía General y Endoscópica, Hospital General “Dr. Manuel Gea González”. Mexico City, Mexico


Abstract

Objective:

The objective of the study was to determine the success rate of ambulatory laparoscopic cholecystectomy with an enhanced recovery after surgery (ERAS) protocol, in patients with symptomatic cholelithiasis.

Materials and methods:

Prospective cohort of patients with symptomatic cholelithiasis underwent elective surgery at the General and Endoscopic Surgery Division of the General Hospital “Dr. Manuel Gea González” from July 2015 to September 2017.

Results:

160 patients were included, the mean age was 36.8 years (15-73 years), and 83.7% were women. We obtained a success rate of 95.6% with this protocol. Two patients required postoperative unplanned hospitalization (1.2%), one of them had surgical treatment (0.6%). Five patients presented post-operative complications (3.1%): one with acute pancreatitis (0.6%) and four (2.5%) were diagnosed with surgical site infection. Overall satisfaction with procedure was close to 99%.

Conclusion:

The performance of ambulatory laparoscopic cholecystectomy with an ERAS protocol in patients with symptomatic cholelithiasis has an adequate success rate, as well as postoperative evolution. Our study shows its safety, reliability, and possibility for routinely implementation without presenting a significant number of complications.

Keywords: Ambulatory laparoscopic cholecystectomy; Enhanced recovery after surgery; Accelerated postoperative recovery protocol; Symptomatic cholelithiasis

Resumen

Objetivo:

Determinar la tasa de éxito de la colecistectomía laparoscópica ambulatoria con un protocolo de recuperación acelerada después de la cirugía (ERAS por sus siglas en inglés), en pacientes con colelitiasis sintomática.

Materiales y métodos:

Cohorte prospectiva de pacientes con colelitiasis sintomática sometidos a cirugía electiva en la División de Cirugía General y Endoscópica del Hospital General “Dr. Manuel Gea González “de julio de 2015 a septiembre de 2017.

Resultados:

Se incluyeron 160 pacientes, la edad media fue de 36,8 años (15-73 años), el 83,7% eran mujeres. Obtuvimos una tasa de éxito del 95,6% con este protocolo. Dos pacientes requirieron hospitalización postoperatoria no planificada (1.2%), uno de ellos recibió tratamiento quirúrgico (0.6%). Cinco pacientes presentaron complicaciones postoperatorias (3.1%): uno con pancreatitis aguda (0.6%) y cuatro (2.5%) fueron diagnosticados de infección del sitio quirúrgico. La satisfacción general con el procedimiento fue cercana al 99%.

Conclusión:

La realización de colecistectomía laparoscópica ambulatoria con protocolo ERAS en pacientes con colelitiasis sintomática tiene una adecuada tasa de éxito, así como de evolución postoperatoria. Nuestro estudio muestra su seguridad, confiabilidad y posibilidad de implementación rutinaria sin presentar un número significativo de complicaciones.

Palabras clave: Colecistectomía laparoscópica ambulatoria; Recuperación acelarada después de la cirugía; Protocolo de recuperación posoperatoria acelerada; Colelitiasis sintomática

Introduction

Symptoms due to gallstone disease are a leading gastrointestinal cause for hospitalization and health-care utilization1.

Definitive treatment consists of performing cholecystectomy, since the risk of developing recurrent symptoms or complications rises to 70% 2 years after the initial presentation. Whenever possible, the laparoscopic approach is preferable over open surgery. Although there are no differences in terms of mortality and complications, the laparoscopic approach reduces hospital stay and shortens the period of convalescence. The complication rate is approximately 5% and includes bile duct injury, bile leakage, hemorrhage, and infection of the surgical wound. The operative mortality rates between 0% and 0.3%2.

Outpatient surgery, defined as one in which the patient may be discharged 12 h after the surgical act, requires clinical practice guidelines that allow the current surgeon to begin or improve their practice3.

In 1995, Dr. Kehlet’s group published the results of a multimodal perioperative care protocol in patients undergoing elective colectomy4, which was later called enhanced recovery after surgery (ERAS)5. Since then, this multimodal approach has been applied in other types of elective surgeries, including cholecystectomy6.

The ERAS protocol includes a combination of techniques in pre-operative management in elective surgery, aimed to attenuating surgical stress and improving post-operative recovery. It consists of optimizing pre-operative preparation for surgery, reducing stress response, avoiding post-operative ileus, accelerating recovery with return to normal function, as well as an early recognition of recovery failure and intervention if necessary7.

Our aim was to evaluate the success rate of ambulatory laparoscopic cholecystectomy with an ERAS protocol in a prospective cohort of patients with symptomatic cholelithiasis.

Materials and methods

We performed a prospective cohort of patients with symptomatic gallstones who underwent elective surgery on an outpatient basis at the General and Endoscopic Surgery Division of the General Hospital “Dr. Manuel Gea González” from July 2015 to September 2017.

Patients with a diagnosis of symptomatic gallstones treated with ambulatory laparoscopic cholecystectomy with an ERAS protocol of any sex, aged between 15 and 75 years, with an American Society of Anesthesiologists (ASA) classification I or II were included in the study. Pregnant women, foreign patients, those with uncontrolled comorbidities, anticoagulant’s user and poor family support were excluded from the study. Elimination criteria included those who retract their consent or did not have post-operative follow-up.

The primary end point was the success rate of ambulatory laparoscopic cholecystectomy, defined as in which the patient was able to be discharged on an outpatient basis (within 12 h), without hospital readmission and no post-operative complications at 30 days follow-up. Secondary end points studied were intraoperative complications, post-operative complications, duration of post-operative hospital stay, unplanned hospital admission, and patients’ satisfaction.

Laparoscopic cholecistectomy with ERAS protocol

PRE-OPERATIVE CARE

Information about the principles of ERAS protocol was given to patients and their caregiver.

An exhaustive pre-operative evaluation by the anesthesiology group was performed for all patients. Patients were admitted on the morning of the surgery. Pre-operative treatment with crystalloid isotonic solution (calculated according patient’s requirements), antibiotics (cefalotine 1 g intravenous [IV]), standard gastric prophylaxis (omeprazole 40 mg IV), and opioid-sparing analgesia (acetaminophen 1 g IV and ketorolac 30 mg IV) were applied.

INTRA-OPERATIVE CARE

Balanced general anesthesia, strict control of fluid therapy, prevention of hypothermia, and adequate analgesia were given to all patients to reduce metabolic stress response.

The surgical technique included three trocars. All port sites were infiltrated before incision using 0.5% bupivacaine. Nasogastric tubes or drains were not inserted. Anti-emesis prophylaxis was achieved with dexamethasone (4 mg IV) and ondansetron (8 mg IV).

POST-OPERATIVE CARE

Patients were taken to a recovery area adjacent to the operating room, where they were monitored and recordings of their vital signs and pain using the visual analog scale (VAS) was obtained. At this stage, antibiotics were suspended and opioid-sparing multimodal analgesia was given (acetaminophen 1 g IV and ketorolac 30 mg IV); in cases of post-operative nausea and vomiting ondansetron was administrated. After reaching a satisfactory level of consciousness, patients were encouraged to walk around freely and start oral intake with clear liquids.

Discharge criteria included pain controlled with oral analgesics (VAS < 4), adequate tolerance to oral intake, ambulation, capacity of micturation, hemodynamic stability, fully mental recovery, surgeon’s approval, and absence of nausea and vomiting. Patients were reviewed and given home post-operative instructions, with special emphasis on alarm symptoms.

Follow-up

All patients were followed up with a phone call on post-operative day 3 and clinical appointments on post-operative days 7 and 30. Post-operative complications, readmissions, and reoperations were recorded if they presented during the 30-day follow-up period.

Sample size

A power calculation was performed using a ninety percent of expected success rate of ambulatory laparoscopic cholecystectomy, with and alpha error = 0.05 and precision of 5%. One hundred and thirty-eight patients were calculated, with a 10% of expected loss, 152 patients were obtained.

Our data were summarized as the means (with minimum and maximum values) or number of patients (percentages).

SPSS version 18.0 for MAC (SPSS Inc. Chicago, IL, USA) was used for analyzing data.

Results

From July 2015 to September 2017, a total of 174 patients with symptomatic cholelithiasis were evaluated, 14 patients were also eliminated because they did not have postoperative follow-up. Therefore, we continued the study with 160 patients, of which 134 were women (83.7%) and 26 (16.2%) were men. Baseline demographic data are shown in table 1.

Table 1 Patients baseline characteristics 

Characteristics n (%)
n (patients) 160 patients
Sex (female:male) 134 (83.7):26 (16.2)
Mean age (years) 36.8 (15-73)
ASA I 150 (93.7)
ASA II 10 (6.2)
Abdominal surgery history 89 (55.6)
Medical history
Diabetes 2 (1.25)
Hypertension 5 (3.12)
Other 4 (2.5)
None 149 (93.1)

ASA: American Society of Anesthesiologists

Intraoperative findings were: 135 patients with cholelithiasis (84.3%), 15 patients with unexpected acute cholecystitis (9.3%), six patients with empyema (3.7%), and four patients with gallbladder hydrops (2.5%). The average post-operative hospital stay in hours was 4.6 ± 7.3 (SD) (Table 2).

Table 2 Surgical findings and characteristics 

Characteristics n (min-max)
Duration of surgery (minutes) 63.8 (25-150)
Bleading (ml) 30.1 (5-100)
Mean postoperative VAS 4.1 (0-10)
Mean postoperative stay (hours) 4.6 (1-95)

Surgical findings n (%)

Cholelithiasis 135 (84.3)
Unexpected Acute Cholecystitis 15 (9.3)
Empyema 6 (3.75)
Gallbladder Hydrops 4 (2.5)

On the other hand, unplanned hospital admission was reported in two patients (1.2%), 1 who underwent pain that did not subside with oral medication and 1 (0.6%) patient required surgical management due to bleeding (0.6%); both patients were diagnosed with gallbladder empyema during surgery. Post-operative complications were seen in 5 (3.1%) patients: 4 (2.5%) of these patients had a diagnosis of residual abscess and 1 (0.6%) patient developed acute pancreatitis. Thus, a success rate of 95.6% (153 patients) was obtained in this protocol (Fig. 1). Other points analyzed were intraoperative complications, which were not found in this protocol, reporting a total of zero cases (0%). Conversion to open surgery was not registered in this protocol.

Figure 1 Success rate of ambulatory laparoscopic cholecystectomy (ALC). Unplanned hospitalization rate account for 1.2% and post-operative complications for 3.12% of our sample. Successful ACL was feasible in 96% of our patients. 

Furthermore, we evaluated patients’ satisfaction with medical care, hospital length stays, and information received by our team. All of them showed a rate close to 99%.

Discussion

Successful ambulatory laparoscopic cholecystectomy (ALC) is one in which the patient can be discharged within 12 h post-operative period, without hospital readmission and no postoperative complications at 30 days. In our study, unplanned admission (1.2%), intraoperative complication including conversion rate to open surgery (0%) and postoperative complication, including surgical site infection and acute pancreatitis (3.1%), account for a total of 4.3% of our sample, achieving a success rate of 95.6% for ambulatory cholecystectomy using an ERAS protocol.

Several studies mention their success rate for this procedure8-12 (Table 3). For instance, Jiménez and Costa11 described their experience with 100 cases of outpatient laparoscopic cholecystectomy subjected to a protocolized anesthesia that included intraperitoneal and parietal use of local anesthesia achieving excellent pain control, the main cause of hospitalization. The frequency of outpatient discharge was 96%. The mean hospital stay of the patients was 7.4 h (7-9.6 h). The morbidity and mortality of the series were 0%; and conversion rate to laparotomy in the series was 0%. No patient required readmission after discharge, and 97% of the patients were very satisfied with the procedure.

Table 3 Several studies were success rate and degree of satisfaction of ambulatory laparoscopic cholecystectomy was reported 

Study (year) Number of patients Success rate of ALC (%) Unplanned hospitalization (%) Readmission (%) Reintervention (%) Conversion to open surgery Degree of satisfaction at 7th day post-operative
Akoh et al.8 258 69.0 31.0 5.0 - - -
Lezana-Pérez et al.9 141 82.0 18.4 3.5 1.4 0.7 82
Soler-Dorda and Marton-Bedia10 511 70.0 30.0 2.8 1.2 3.3 -
Jiménez and Costa11 100 96.0 4.0 0.0 - 0 97
Sala-Hernández et al.12 164 92.8 5.5 1.8 - 1.2 87.10
Mendoza-Velez et al. 160 95.6 1.2 0.0 0.6 0 99

ALC: ambulatory laparoscopic cholecystectomy

Tang and Dong13 performed a meta-analysis comparing short-stay surgery versus night-stay surgery in patients with lithiasic cholecystitis after laparoscopic cholecystectomy. It included 12 studies, with a total of 1,430 patients, 650 were classified as ambulatory cholecystectomy and 780 as overnight stay surgery. Within the results they reported morbidity of 5.2% and 6% for the group of short stay surgery and night stay surgery, respectively, being statistically not significant. Regarding prolonged stay or unplanned hospital admission, they found 13.1% in the ambulatory surgery group. The main causes were conversion to open surgery, nausea or vomiting that did not give way to medications, pain, and use of drainage. While in the overnight stay group, a 12.1% length of hospital stay was found for the same reasons, being statistically not significant between groups. The percentage of readmission once hospital discharge was 0-4.8% in the short stay group, while in the overnight stay group it was 0-5.2%, the main diagnoses in both groups being infections, pancreatitis, and biliary leak. However, this was also not statistically significant. Other points that were analyzed were the quality of life on the day of surgery and the time of return to work activities; however, the differences were not statistically significant. The authors concluded that outpatient laparoscopic cholecystectomy is safe, effective and cheaper and can be performed without major problems in selected patients.

Lezana et al.9 analyzed the effectiveness and quality of outpatient cholecystectomy versus conventional laparoscopic cholecystectomy management. In this study, no intervention was performed regarding pain control. The overall satisfaction index was 82% and the satisfaction indicator for the care received was 81%, both above the previously set standard. Regarding the other parameters analyzed (mortality, morbidity, reinterventions, readmissions, and stay) there was no difference between the two groups as in other studies cited.

In our study, the degree of satisfaction expressed was either excellent or very good in 99% of our sample on the 7th post-operative day. We valued medical care (99.3%), hospital stay length (99.3%), and information received before procedure (98.7%), achieving a great acceptance between our patients.

Based on this study, we intend to carry out new prospective studies to assess outpatient management with ERAS protocol in patients with symptomatic cholelithiasis.

Conclusion

The performance of ALC with an accelerated postoperative recovery protocol in patients with symptomatic gallbladder lithiasis has a significant success rate in the period investigated and similar to the reported in international literature. Our study supports the safety, reliability, and possibility for implementation of routine ALC with ERAS protocol, with a demonstrated high degree of patient satisfaction. Our data advocate the inclusion of ALC as a treatment of choice for symptomatic cholelithiasis that minimizes hospitalizations. However, our sample is limited to one center and no control group was followed.

Acknowledgments

The authors thank their medical interns for collecting information for the protocol.

References

1. Peery AF, Crockett SD, Barritt AS, Dellon ES, Eluri S, Gangarosa LM, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149:1731. [ Links ]

2. Dooley JS, Lok AS, Garcia-Tsao GA, Pinzani M. Gallstones and benign biliary disease. In:Heathcote EJ, editors. Sherlock's Diseases of the Biliary System. 12th ed. Oxford:Wiley-Blackwell;2011. 257-93. [ Links ]

3. Kraft K, Mariette C, Sauvanet A, Balon JM, Douard R, Fabre S, et al. Indications for ambulatory gastrointestinal and endocrine surgery in adults. J Visc Surg. 2011;148:69-74. [ Links ]

4. Bardram L, Funch-Jensen P Crawford ME, Kehlet H. Recovery after laparoscopic colonic surgery with epidural analgesia, and early oral nutrition and mobilisation. Lancet.1995;345:763-4. [ Links ]

5. Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery:a review. JAMA Surg.2017;152:292-8. [ Links ]

6. Zhang N, Gang W, Zhou Y, Liao Z, Guo J, Liu Y, et al. Use of enhanced recovery after surgery (ERAS) in laparoscopic cholecystectomy (LC) combined with laparoscopic common bile duct exploration (LCBDE):a cohort study. Med Sci Monit. 2020;26:e924946. [ Links ]

7. Lassen K, Coolsen ME, Slim K, Carli F, de Aguilar-Nacimiento, JE, Schäfer M, et al. Guidelines for perioperative care for pancreaticoduodenectomy:enhanced recovery after surgery (ERAS) society recommendations. World J Surg. 2012;37:240-58. [ Links ]

8. Akoh AJ, Watson WA, Bourne TP. Day case laparoscopic cholecystectomy:reducing the admission rate. Int J Surg. 2011;9:63-7. [ Links ]

9. Lezana Pérez MA, Carreño Villarreal G, Lora Cumplido P, Álvarez Obregón R. Colecistectomía laparoscópica ambulatoria versus con ingreso:estudio de efectividad y calidad. Cir Esp. 2013;91:424-31. [ Links ]

10. Soler-Dorda G, Marton-Bedia P. Factores asociados a ingreso no previsto tras colcistectomia laparoscopica en régimen de cirugía mayor ambulatoria. Cir Esp. 2016;92:93-9. [ Links ]

11. Jiménez M, Costa D. Outpatient laparoscopic cholecystectomy control:a series of 100 cases. Cir Esp. 2015;93:181-6. [ Links ]

12. Sala-Hernández A, Granero Castro P, Montalva Orón E, Maupoey Ibáñez J, García-Domínguez R, Bueno Lledo J, et al. Evaluación de la segurada y satisfacción de los pacientes en un programa de colecistetomía laparoscopicoa ambulatoria con cierrios expandidos. Cir Esp. 2020;98:173-410. [ Links ]

13. Tan H, Dong A, Yan L. Day surgery versus overnight stay laparoscopic cholecystectomy:a systematic review and meta-analysis. Dig Liver Dis. 2015;47:556-61. [ Links ]

FundingThe authors declare that no type of funding was received.

Ethical disclosures

Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data. The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent. The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.

Received: May 25, 2021; Accepted: January 07, 2022

* Correspondence: Erika Barlandas-Quintana E-mail: barlandas@gmail.com

Conflicts of interest

The authors declare that there are no conflicts of interest.

Creative Commons License Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer. This is an open access article under the CC BY-NC-ND license